What is Biovaxys Technology Corp?
, a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics. The company offers DPX immune educating technology platform and HapTenix neoantigen tumor cell construct platform for treating cancers, infectious diseases, antigen desensitization, and other immune diseases. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 1.81M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.